| Applicant | NOPHO project reference number | NOPHO project name | Year | Provided samples with cells | Provided samples with DNA | Provided samples with RNA | Provided samples with serum |
| Randi Hovland Henrik Hasle | Presentation in Turku supported | KIT och RAS mutations in CBS AML A NOPHO-AMLstudy | 2011 | 18 | | | |
| Julie Damgaard | | | 2011 | 2 | | | |
| Erik Forrestier Sofie Degerman | | DNA promoter methylation as a prognostic marker in T-ALL | 2013 | 68 | | | |
| Louise Rold Helt | | | 2014 | 5 | | | |
| Gudmar Lönnerholm | | | 2015 | 563 | | | |
| Kjeld Schmiegelow Stine Nygaard Nielsen | Study 82 Approved by the board | Study 82 Aquired thiopurine resistance in relapsing ALL | 2015 | 3 | | | |
| Kjeld Schmiegelow Stine Nygaard Nielsen | Study 82 Approved by the board | Study 82 Aquired thiopurine resistance in relapsing ALL | 2015 | 2 | | | |
| Kjeld Schmiegelow Hanne Marquart | Study 84 CRLF2/IL7 | Study 84 CRLF2/IL7: Investigation of activity and expression of the IL7 related signaling pathway including STAT-5 phosphorylation in BCP- and T-ALL in patients from the NOPHO-ALL2008 protocol | 2015 | 263 | | | |
| Anna Andersson | Study 118 | Study 118 Genome-wide analysis of MLL-rearranged leukemia and fuctional studies to identify | 2016 | 15 | | | |
| Sanne Noort | NOPHO-2015-15/R1-(20) | Part of NOPHO-AML 2004, sent to Erasmus, Holland | 2016 | 21 | | | |
| Kim Ramme | | | 2016 | 3 | | | |
| Britt Gustavsson Kristin Mattsson | | Molecular biological studies on etiologic factors in leukemia in children via analysis of PKU blood samples | 2016 | | 3 | | |
| Linda Holmfeldt | | Multi-level analysis of acute myeloid leukemia | 2016-2017 | 69 | | | |
| Kristian Juul-Dam | | Early relapse detection study | 2017 | 2 | | | |
| Morten Herlin | | AML-NOS, Genomic profiling of pediatric AML | 2018 | 41 | | | |
| Erik Delsing Malmberg | | Early detection of relapse AML | 2018 | 2 | | | |
| Ann-sofie Skou | NOPHO 2017-11 (72) | Early relaps NOPHO AML / Sensitive methods for AML | 2019 | 4 | | | |
| Olli Lohi | NOPHO 2018-10R | NOPHO project n:o 96 Genomics-based tools for personalized treatment to reduce chemotherapy burden in pediatric leukemia (GEPARD) | 2019 | | 28 | 28 | |
| Ninna Brix Uggerby, Arhus, Dk | NOPHO-2019-15 – (124) | The use of biomarkers S100, M-ficolin, CL-K1 and MASP-3 in separating children with leukemia and joint involvement from children with juvenile idiopathic arthritis | 2020 | | | | 151 |
| Sofie Degerman | NOPHO Study No 70 | NOPHO Study No 70 Prognostic and biological relevance of DNA methylation in T-ALL – an extension of NOPHO Study No 70 | 2020 | | 134 | | |
| Jochen Buchner | Approved by NOPHO Board, ALL WG, Scientific committee och LLC | Not a formal NOPHO projekt | 2020 | 4 | | | |
| Anders Östlund/Lars Palmqvist | NOPHO-2018-8/R1 | Determine incidence, prognosis and mechanisms for acute myeloid leukemia with t(7;12)(q36;p13) | 2021 | | 17 | 38 | |
| Sofie Degerman | NOPHO Study No 70 | NOPHO Study No 70 Prognostic and biological relevance of DNA methylation in T-ALL – an extension of NOPHO Study No 70 | 2021 | | | 125 | |
| Vasilios Zachariadis | NOPHO-2019-14-122 | Analys av genetiska förändringar och genuttryck vid akut lymfatisk leukemi hos barn | 2021 | 1 | | | |
| | | | Total | 1086 | 182 | 191 | 151 |
